Skip to main content
Livermore
Livermore
ZHEN

Oric Pharmaceuticals, Inc.

ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001796280

In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.

Holders of 5% or more of ORIC

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oric Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ORIC
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nextech Crossover I GP S.a r.l.13G/A8.40%7.16M shares–Jul 7, 20233 filingsAug 14, 2025SEC
Viking Global Investors LPSuperinvestorViking Global Investors13G/A7.80%8.26M shares−2.19 ppfrom 9.99%Jan 30, 20244 filingsMay 15, 2026SEC
EcoR1 Capital, LLC13G6.90%6.73M shares–Feb 16, 20216 filingsAug 5, 2025SEC
BlackRock, Inc.13G5.60%5.47M shares+1.40 ppfrom 4.20%Oct 22, 20244 filingsJan 21, 2026SEC
Price T Rowe Associates Inc13G5.40%5.39M sharesNewMay 15, 20261 filingMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

60 Schedule 13D and 13G filings on Oric Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ORIC
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20265:48 PM ETViking Global Investors LPand 9 othersSuperinvestorViking Global Investors13G/A7.80%8.26M shares−2.19 ppfrom 9.99%Mar 31, 2026SEC
May 15, 20264:33 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G/A4.20%4.32M shares−1.60 ppfrom 5.80%Below 5%Mar 31, 2026SEC
May 15, 20264:17 PM ETPoint72 Asset Management, L.P.and 2 others13G/A0.00%0 shares−5.10 ppfrom 5.10%Below 5%Mar 31, 2026SEC
May 15, 202610:07 AM ETPrice T Rowe Associates Inc13G5.40%5.39M sharesNewMar 31, 2026SEC
May 12, 20265:05 PM ETPfizer Inc13G/A3.30%3.44M shares–Below 5%Mar 31, 2026SEC
Feb 17, 20266:15 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G/A5.80%5.68M shares−1.90 ppfrom 7.70%Dec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G5.60%5.47M shares+1.40 ppfrom 4.20%Dec 31, 2025SEC
Nov 17, 20258:17 PM ETColumn Group II, LPand 3 others13G/A3.70%3.64M shares–Below 5%Sep 30, 2025SEC
Nov 13, 20256:15 PM ETAlkeon Capital Management LLCand 1 other13G/A4.60%4.50M shares–Below 5%Sep 30, 2025SEC
Aug 14, 20255:34 PM ETViking Global Investors LPand 10 othersSuperinvestorViking Global Investors13G/A9.99%8.73M shares+0.79 ppfrom 9.20%Jun 30, 2025SEC
Aug 14, 20254:54 PM ETNextech Crossover I GP S.a r.l.and 4 others13G/A8.40%7.16M shares–Jun 30, 2025SEC
Aug 14, 20254:05 PM ETSr One Capital Management, LLCand 7 others13D/A4.75%4.62M shares−0.65 ppfrom 5.40%Below 5%Aug 12, 2025SEC
Aug 5, 20256:36 PM ETEcoR1 Capital, LLCand 2 others13G6.90%6.73M shares–Jul 29, 2025SEC
Jul 17, 20257:54 PM ETBlackRock, Inc.13G/A4.20%3.62M shares–Below 5%Jun 30, 2025SEC
Jun 5, 20255:17 PM ETSr One Capital Management, LLCand 7 others13D5.40%4.62M sharesNewMay 29, 2025SEC
Jun 4, 20254:32 PM ETPoint72 Asset Management, L.P.and 2 others13G5.10%4.40M sharesNewMay 29, 2025SEC
May 30, 20254:35 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G7.70%6.60M shares+3.20 ppfrom 4.50%Apr 8, 2025SEC
May 15, 20255:47 PM ETVenrock Healthcare Capital Partners III, L.P.and 6 others13G/A4.50%3.18M shares–Below 5%Mar 31, 2025SEC
May 15, 20254:35 PM ETViking Global Investors LPand 10 othersSuperinvestorViking Global Investors13G/A9.20%6.57M shares–Mar 31, 2025SEC
May 15, 20259:42 AM ETFrazier Life Sciences Public Fund, L.P.and 16 others13G/A2.00%1.41M shares–Below 5%Mar 31, 2025SEC
Feb 12, 20259:30 AM ETFMR LLCand 1 other13G/A3.50%2.47M shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Column Group II, LP13G/AOld format–––SEC
Nov 14, 2024Nextech Crossover I GP S.a r.l.13G/AOld format–––SEC
Nov 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Nov 13, 2024Alkeon Capital Management LLC13G/AOld format–––SEC
Nov 12, 2024FMR LLC13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 22, 2024BlackRock, Inc.13GOld format–New–SEC
Mar 11, 2024FMR LLC13G/AOld format–––SEC
Feb 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 13, 2024Prosight Management, LP13G/AOld format–––SEC
Feb 13, 2024Alkeon Capital Management LLC13G/AOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 7, 20245:09 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 6, 2024Millennium Management LLC13G/AOld format–––SEC
Feb 1, 2024Venrock Healthcare Capital Partners III, L.P.13GOld format–New–SEC
Jan 30, 2024Viking Global Investors LPSuperinvestorViking Global Investors13GOld format–New–SEC
Jan 29, 20245:25 PM ETBlackRock Inc.13GOld format–––SEC
Jan 25, 2024Frazier Life Sciences Public Fund, L.P.13GOld format–New–SEC
Jul 7, 2023Nextech Crossover I GP S.a r.l.13GOld format–New–SEC
Jun 12, 2023Prosight Management, LP13GOld format–New–SEC
Feb 13, 2023Alkeon Capital Management LLC13G/AOld format–––SEC
Feb 10, 2023EcoR1 Capital, LLC13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Feb 6, 2023Victory Capital Management Inc13G/AOld format–––SEC
Jan 20, 2023Millennium Management LLC13GOld format–New–SEC
Dec 29, 2022Pfizer Inc13GOld format–New–SEC
Dec 27, 2022OrbiMed Advisors LLC13D/AOld format–––SEC
Jul 8, 20224:57 PM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2022EcoR1 Capital, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell Oric Pharmaceuticals, Inc. shares, newest first.

Form 144 notices for ORIC
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jun 26, 20236:25 PM ETJacob ChackoAffiliate20.0K$160.6KJun 26, 202310b5-1J.P. Morgan Securities LLCSEC